Health
Moderna begins human trial for multi-strain mRNA flu vaccine – Macau Business
International, MNA | US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine…
US biotech firm Moderna said Wednesday it had dosed its first participants in a human study of an mRNA vaccine that targets multiple strains of influenza.
The company intends to recruit 180 adults in the United States for the Phase 1/2 portion of the trial…
Continue Reading